Richter Gedeon Vegyeszeti Gyar Rt

Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.

Biogal Gyogyszergyar

Karoly Lapis

Bela Szende

Lajos Kisfaludy

Laszlo Kopper

Laszlo Szporny

Gyorgy Hajos

Sandor Virag

Gyula Sebestyen

Tamas Szuts

Katalin Marmarosi

Laszlo Denes

Istvan Schon

Lajos Kovacs

Janos Balint

Erno Tyihak

Sandor Jancso

Rezso Bognar

Jozsef Lengyel

Istvan Kovacs

Olga Nyeki Nee Kuprina

Janos Feher

Gyorgy Dobo

Geza Horvath

Katalin Kalloy

Maria Hornyak

Kalman Medzihradszky

Jozsef Schawartz

Ildiko Mihok Nee Borbely

Zoltan Gyorgydeak

Andras Jeney

Judit Krusper Nee Ham

Attila Jakab

Ferenc Pusztai

Terezia Mile

Helga Suli

Andras Jenei

Mariann Fekete Nee Huszka

Hedvig Medzihradszky Nee Schweiger

Andreas Jeney

Karoly Simon

Antileukemic and immunostimulant peptides

The invention relates to new peptide derivatives of the general Formula I ##STR1## wherein R is a group derived from any oligopeptide by removing a terminal amino group, or--if the oligopeptide comprises a diamino carboxylic acid--the amino group in the .omega.-position, or the terminal and .omega.-amino groups; and

Nitroso-N-(.beta.-chloro ethyl)-carbamoyl peptides

The invention relates to novel thiazolidine-4(S)-carboxylic acid derivatives of the general formula (I) ##STR1## wherein R.sup.1 stands for an optionally substituted furyl, pyrrolyl, thienyl, benzofuryl, benzopyrrolyl, benzothienyl, phenyl, pyridyl, quinolinyl, isoquinolinyl or indanyl group or a C.sub.1-4 alkyl or C.sub.2-4 alkenyl group optionally substituted by a hydroxyl, carboxyl or halogen fenoxy group,

Thiazolidinecarboxylic acid derivatives and treatment of liver diseases

The present invention relates to synergistic pharmaceutical compositions for the treatment of liver disorders comprising 5-aminoimidazole-4-carboxamide orthophosphate (AICA-phosphate) as active ingredient in association with vitamins, preferably with vitamin B and/or E and optionally with other pharmaceutical excipients.

Synergistic pharmaceutical compositions

There are disclosed pharmaceutical compositions comprising at least one cytostatic agent and N.sup..epsilon. -trimethylthyllysin or a pharmaceutically acceptable salt thereof, optionally in association with conventional pharmaceutical carriers and other additives. The new compositions possess a reduced toxicity compared with the cytostatic agents administered alone.

Pharmaceutical compositions and process for the preparation of same

Growing community of inventors

Budapest, Hungary

Karoly Lapis